Last reviewed · How we verify
Screening Platform
At a glance
| Generic name | Screening Platform |
|---|---|
| Sponsor | SWOG Cancer Research Network |
| Modality | Small molecule |
| Phase | Phase 2 |
Approved indications
Common side effects
Key clinical trials
- A Modified Platform Trial of Multiple CAMPs for the Management of Diabetic Foot Ulcers and Venous Leg Ulcers (NA)
- Early Detection of Skin Tumors Using a Telemedicine Tool in Primary Care (NA)
- Expanding Coverage of Severe Acute Malnutrition (SAM) Treatment in Kenya (NA)
- LasaiON is an Evidence-informed, Multimodal Self-regulation Program Designed to Reduce Emotional Distress and Strengthen Stress-regulation Skills by Combining Transcutaneous Auricular Vagus Nerve Stimulation (taVNS) With Breathing Supported by Heart-rate Variability Biofeedback (HRV-B; emWave). (NA)
- Adolescent Wellness Visits in Tanzania (NA)
- Telemedicine-based Integrated Management of Atrial Fibrillation and Heart Failure in Older Patients in Village Clinics (NA)
- Pilot of Exercise and Asthma Control (NA)
- Early Support After Exposure to Trauma (NA)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Screening Platform CI brief — competitive landscape report
- Screening Platform updates RSS · CI watch RSS
- SWOG Cancer Research Network portfolio CI